MEDICAL NEWS TODAY | DAILY NEWS
New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, to a rare eye disease that may cause vision loss.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
New study: GLP-1 medications may double the risk of blinding eye disease
 
READ ON
→
All about soft tissue sarcoma in the leg
 
READ ON
→
Can black currant seed oil help treat eczema?
 
READ ON
→
 
 
 
 
 
Pets and childhood eczema: Is there a link?
 
 
 
 
Could fiber be nature’s Ozempic? Find out in our new podcast episode